Calliditas Therapeutics AB (publ) (CALT) Ownership

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$40
Day's range
$43

Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CROSSMARK GLOBAL HOLDINGS, INC. 11/04/2024 16.12 K $655.00 K   100.00% 0.03%
ADVISORS PREFERRED, LLC 10/15/2024 2.02 K $81.51 K   100.00% 0.00%
RHUMBLINE ADVISERS 11/12/2024 303 $12.15 K   50.00% 0.00%
MISSOURI TRUST & INVESTMENT CO 11/05/2024 35 $1.40 K   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 11/14/2024 0 $0   -100.00% 0.00%
WELLS FARGO & COMPANY/MN 11/13/2024 0 $0   -100.00% 0.00%
MORGAN STANLEY 05/14/2025 0 $0   -100.00% 0.00%
BVF INC/IL 11/14/2024 0 $0   -100.00% 0.00%
IRONWOOD INVESTMENT MANAGEMENT LLC 11/14/2024 0 $0   -100.00% 0.00%
CIBC PRIVATE WEALTH GROUP, LLC 11/13/2024 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 11/14/2024 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 0 $0   -100.00% 0.00%
COLONIAL TRUST ADVISORS 11/12/2024 0 $0   -100.00% 0.00%
UBS GROUP AG 11/14/2024 0 $0   -100.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 11/13/2024 0 $0   -100.00% 0.00%
PENDERFUND CAPITAL MANAGEMENT LTD. 11/14/2024 0 $0   -100.00% 0.00%
EVERSOURCE WEALTH ADVISORS, LLC 11/08/2024 0 $0   -100.00% 0.00%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2024 0 $0   -100.00% 0.00%
GLOBAL RETIREMENT PARTNERS, LLC 10/16/2024 0 $0   -100.00% 0.00%
OPTIVER HOLDING B.V. 11/14/2024 0 $0   -100.00% 0.00%
PLANNING CAPITAL MANAGEMENT CORP 11/06/2024 0 $0   -100.00% 0.00%

Calliditas Therapeutics AB (publ) institutional Ownership - FAQ's

During the previous two years, 4 institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ). The most heavily invested institutionals were:

Planning Capital Management Corp: 0

Cutler Group LLC / CA: 0

Nalls Sherbakoff Group, LLC: 18

NEXT Financial Group, Inc: 0

0.03% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors.

Institutional investors have bought a total of 18 shares in the last 24 months. This purchase volume represents approximately $720 in transactions.